Results 31 to 40 of about 334,470 (291)

Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review

Research and Practice in Thrombosis and Haemostasis, 2021
Introduction Postthrombotic syndrome (PTS) is a form of secondary chronic venous insufficiency (CVI) that occurs after deep vein thrombosis (DVT). Effective treatments for PTS are lacking.
Ke Xuan Li, Gisele Diendéré, Jean‐Philippe Galanaud, Nada Mahjoub, Susan R. Kahn   +4 more
doaj   +1 more source

Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World Setting

Frontiers in Cardiovascular Medicine, 2021
Background: In the clinical setting, the economic benefits of direct oral anticoagulants (DOACs) in elderly patients with atrial fibrillation (AF) remain unclear.
Yue Wu, Yue Wu, Chi Zhang, Chi Zhang, Chi Zhang, Zhi-Chun Gu, Zhi-Chun Gu, Zhi-Chun Gu   +7 more
doaj   +1 more source

Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum

Journal of Thrombosis and Thrombolysis, 2020
Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases, result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic of poor outcomes. While some, but not all, laboratory findings appear similar
G. Barnes, Allison E. Burnett, Arthur L. Allen, Marilyn Blumenstein, N. Clark, A. Cuker, William E. Dager, S. Deitelzweig, S. Ellsworth, D. Garcia, S. Kaatz, Tracy Minichiello   +11 more
semanticscholar   +1 more source

Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial.

JAMA cardiology, 2022
Importance The optimal treatment of intermediate-high-risk pulmonary embolism (PE) remains unknown. Objective To assess the effect of conventional catheter-directed thrombolysis (cCDT) plus anticoagulation vs anticoagulation monotherapy in improving ...
P. Sadeghipour, Y. Jenab, J. Moosavi, K. Hosseini, B. Mohebbi, A. Hosseinsabet, S. Chatterjee, H. Pouraliakbar, S. Shirani, M. Shishehbor, A. Alizadehasl, M. Farrashi, Mohammad Ali Rezvani, F. Rafiee, A. Jalali, Sina Rashedi, O. Shafe, Jay S Giri, M. Monreal, D. Jiménez, I. Lang, M. Maleki, S. Goldhaber, H. Krumholz, G. Piazza, B. Bikdeli   +25 more
semanticscholar   +1 more source

The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice : systematic review and economic evaluation [PDF]

, 2015
Funding The National Institute for Health Research Health Technology Assessment programme.Peer reviewedPublisher ...
, , , , , , , , , , , , , , , , , , , , Ahmad, Ansell, Ascione, Azarnoush, Bauman, Bauman, Bauman, Bayer, Bereznicki, Bloomfield, Braun, Briggs, Bronnum-Hansen, Brown, Cayley, Christensen, Christensen, Christensen, Christensen, Christensen, Christensen, Connock, Connolly, Cromheecke, Curtis, Dauphin, DeWilde, Dorman, Drummond, Dunning, Edwards, Eitz, Fitzmaurice, Fitzmaurice, Fitzmaurice, Friberg, Friberg, Fuster, Gadisseur, Gadisseur, Gailly, Gallagher, Garcia-Alamino, Gardiner, Gardiner, Go, Hallan, Havrda, Hemkens, Heneghan, Heneghan, Hentrich, Higgins, Hobbs, Horstkotte, Horstkotte, Horstkotte, Hylek, Jackson, Jones, Jones, Jowett, Kannel, Khan, Kind, Kitchen, Koertke, Koertke, Koertke, Kvidal, Körtke, Körtke, Lafata, Lee, Marini, Matchar, Matchar, Matchar, McCahon, Menéndez-Jándula, Moher, Moon, Muller, Murray, Paioni, Pollack, Rasmussen, Regier, Robinson, Rose, Ruel, Ryan, Ryan, Ryan, Saka, Sawicki, Sawicki, Schmidt, Sidhu, Siebenhofer, Siebenhofer, Slot, Sobieraj-Teague, Sola-Morales, Soliman Hamad, Spackman, Sudlow, Sullivan, Sundberg, Sunderji, Sunderji, Taborski, Tamayo, Vahanian, van, Verret, Visnansky, Voller, Völler, Wallentin, Wallentin, Wang, Wardlaw, Wells, Williams, You   +145 more
core   +1 more source

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

Research and Practice in Thrombosis and Haemostasis, 2021
Background Coagulopathy has been reported in severely ill patients with coronavirus disease 2019 (COVID‐19). It is unclear whether outpatients with COVID‐19 who are treated with vitamin K antagonists (VKAs) have unstable anticoagulation.
Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter, The Dutch COVID & Thrombosis Coalition   +6 more
doaj   +1 more source

Major Outcomes in Atrial Fibrillation Patients with One Risk Factor: Impact of Time in Therapeutic Range [PDF]

, 2016
BACKGROUND: The benefits and harms of oral anticoagulation (OAC) therapy in patients with only one stroke risk factor (i.e. CHA2DS2-VASc= 1 in males, or 2 in females) has been subject of debate.
Lip, Gregory Y. H., Proietti, Marco
core   +2 more sources

Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review

Journal of Clinical Medicine, 2022
The development of extracorporeal life support technology has added a new dimension to the care of critically ill patients who fail conventional treatment options. Extracorporeal membrane oxygenation (ECMO)—specialized temporary life support for patients
Saša Rajšić, Robert Breitkopf, Dragana Jadzic, Marina Popović Krneta, H. Tauber, B. Treml   +5 more
semanticscholar   +1 more source

Survival Benefit of Anticoagulation Therapy in End Stage Kidney Disease Patients with Atrial Fibrillation: A Single Center Retrospective Study

Medicina, 2021
Background and Objectives: Although the need for anticoagulation to prevent thromboembolism is increasing and non-vitamin K antagonist oral anticoagulants (NOACs) have been tried, there is still controversy about the efficacy of anticoagulation in ...
Mi-Ryung Kim, Deok-Gie Kim, Han-Wul Shin, Sung-Hwa Kim, Jae-Seok Kim, Jae-Won Yang, Byoung-Geun Han, Seong-Ok Choi, Jun Young Lee   +8 more
doaj   +1 more source

A systematic review and meta-analysis of systemic intraoperative anticoagulation during arteriovenous access formation for dialysis [PDF]

, 2015
Purpose: Surgical arteriovenous fistula (AVF) or graft (AVG) is preferred to a central venous catheter for dialysis access. Surgical access may suffer thrombosis early after placement and systemic anticoagulation during surgical access formation may ...
Carradice, Daniel, Cayton, Thomas, Chetter, Ian C., Harwood, Amy, Smith, George E., Souroullos, Panos   +5 more
core   +1 more source